Journal
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 32, Issue 4, Pages 677-695Publisher
ELSEVIER SCI LTD
DOI: 10.1006/jmcc.2000.1111
Keywords
ATP-sensitive potassium channels; mitochondria; heart; myocardial ischemia, preconditioning
Categories
Funding
- NIGMS NIH HHS [GM55324, GM31086] Funding Source: Medline
Ask authors/readers for more resources
ATP-sensitive potassium channels (K-ATP) have been thought to be a mediator of cardioprotection for the last ten years. Significant progress has been made in learning the pharmacology of this channel as well as its molecular regulation with regard to cardioprotection. K-ATP openers as a class protect ischemic/reperfused myocardium and appear to do so by conservation of energy. The reduced rate of ATP hydrolysis during ischemia exerted by these openers is not due to a cardioplegic effect and is independent of action potential shortening. Compounds have been synthesized which retain the cardioprotective effects of first generation K-ATP openers, but are devoid of vasodilator and cardiac sarcolemmal potassium outward currents. These results suggest receptor or channel subtypes. Recent pharmacologic and molecular biology studies suggest the activation of mitochondrial K-ATP as the relevant cardioprotective site, Implications of these results for future drug discovery and preconditioning are discussed. (C) 2000 Academic Press.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available